| Franklin Dao, MD | |
|
1329 Lusitana St Ste B2, Honolulu, HI 96813 | |
| (808) 599-4200 | |
| (808) 599-4300 |
| Full Name | Franklin Dao |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 1329 Lusitana St Ste B2, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174617609 | NPI | - | NPPES |
| MD9846-04 | Other | HI | MDX |
| 250975-02 | Medicaid | HI | |
| 5396167 | Other | HI | FIRST HEALTH |
| 192262 | Other | HI | HMN |
| 99-0154598 | Other | HI | AMER BENEFIT |
| 356341 | Other | HI | UHA |
| D21669-9 | Other | HI | HMSA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD-9846 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Queens Medical Center | Honolulu, HI | Hospital |
| Kapiolani Medical Center For Women & Children | Honolulu, HI | Hospital |
| Pali Momi Medical Center | Aiea, HI | Hospital |
| Kuakini Medical Center | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ttnydandd Obgyn Inc | 0244127124 | 4 |
News Archive
Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the company's investigational therapy, TREANDA (bendamustine HCl), for the treatment of chronic lymphocytic leukemia (CLL).
UnitedHealthcare will host a series of educational seminars at the Jersey City Medical Center in Jersey City, N.J., to help baby boomers and other Medicare beneficiaries learn more about the Medicare program so they can make confident health care coverage choices.
Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology in Orlando.
Obese youths with acute lymphoblastic leukemia (ALL) are known to have worse outcomes than their lean counterparts. To find out why, investigators at Children's Hospital Los Angeles studied patients who were obese at the time of their diagnosis with ALL to determine if body mass index (BMI) impacted response to initial chemotherapy. This response to initial chemotherapy (or induction therapy) is measured by the absence of leukemia cells in the bone marrow.
The Children's Health Insurance Program Reauthorization Act (CHIPRA) legislation required a core set of recommended health care quality measures to be identified for voluntary use by State Medicaid and the Children's Health Insurance Programs (CHIP), which together cover almost 40 million American children and adolescents.
› Verified 2 days ago
| Entity Name | Ttnyd&d Obgyn Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083778443 PECOS PAC ID: 0244127124 Enrollment ID: O20040304000113 |
News Archive
Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the company's investigational therapy, TREANDA (bendamustine HCl), for the treatment of chronic lymphocytic leukemia (CLL).
UnitedHealthcare will host a series of educational seminars at the Jersey City Medical Center in Jersey City, N.J., to help baby boomers and other Medicare beneficiaries learn more about the Medicare program so they can make confident health care coverage choices.
Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology in Orlando.
Obese youths with acute lymphoblastic leukemia (ALL) are known to have worse outcomes than their lean counterparts. To find out why, investigators at Children's Hospital Los Angeles studied patients who were obese at the time of their diagnosis with ALL to determine if body mass index (BMI) impacted response to initial chemotherapy. This response to initial chemotherapy (or induction therapy) is measured by the absence of leukemia cells in the bone marrow.
The Children's Health Insurance Program Reauthorization Act (CHIPRA) legislation required a core set of recommended health care quality measures to be identified for voluntary use by State Medicaid and the Children's Health Insurance Programs (CHIP), which together cover almost 40 million American children and adolescents.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Franklin Dao, MD 1329 Lusitana St Ste B2, Honolulu, HI 96813-2401 Ph: (808) 599-4200 | Franklin Dao, MD 1329 Lusitana St Ste B2, Honolulu, HI 96813 Ph: (808) 599-4200 |
News Archive
Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the company's investigational therapy, TREANDA (bendamustine HCl), for the treatment of chronic lymphocytic leukemia (CLL).
UnitedHealthcare will host a series of educational seminars at the Jersey City Medical Center in Jersey City, N.J., to help baby boomers and other Medicare beneficiaries learn more about the Medicare program so they can make confident health care coverage choices.
Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology in Orlando.
Obese youths with acute lymphoblastic leukemia (ALL) are known to have worse outcomes than their lean counterparts. To find out why, investigators at Children's Hospital Los Angeles studied patients who were obese at the time of their diagnosis with ALL to determine if body mass index (BMI) impacted response to initial chemotherapy. This response to initial chemotherapy (or induction therapy) is measured by the absence of leukemia cells in the bone marrow.
The Children's Health Insurance Program Reauthorization Act (CHIPRA) legislation required a core set of recommended health care quality measures to be identified for voluntary use by State Medicaid and the Children's Health Insurance Programs (CHIP), which together cover almost 40 million American children and adolescents.
› Verified 2 days ago
Deborah A. Buccigrossi, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1010 Pensacola St, Honolulu, HI 96814 Phone: 808-432-2000 | |
Cheryl Lynn Tanguilig Rudy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St, Suite 760, Honolulu, HI 96826 Phone: 808-947-5606 Fax: 808-947-5805 | |
Dr. Gwendolyn Patricia Chung, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1441 Kapiolani Boulevard, Suite 1810, Honolulu, HI 96814 Phone: 808-949-5308 Fax: 808-943-0963 | |
Dr. Hong-ru Chen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St, Ste 515, Honolulu, HI 96826 Phone: 808-951-6006 Fax: 818-875-0005 | |
Dr. Benakar Fonseca Batista, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St, Honolulu, HI 96826 Phone: 808-983-6931 | |
Asia Ayabe, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-983-6000 | |
Rosemarie S. W. Chang, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1319 Punahou St Ste 515, Honolulu, HI 96826 Phone: 808-951-6006 Fax: 808-943-2634 |